Portfolio company
Nomic Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Nomic Bio develops high-throughput protein profiling platforms and assays for pharmaceutical, biotechnology and academic researchers to accelerate drug and biomarker discovery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Nplex Biosciences
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
Glyphic
This biotechnology company develops a protein sequencing platform for researchers to accelerate drug discovery and proteomic analysis.
Alamar Biosciences
This company develops high-sensitivity proteomics platforms and protein biomarker detection assays for life sciences researchers and clinicians in drug development and disease research.
Glyphic Bio
This company develops a single-molecule protein sequencing platform for researchers to identify amino acids and post-translational modifications in the human proteome.
Glyphic Biotechnologies
This company develops a single-molecule protein sequencing platform for researchers and institutions focused on biological research and drug discovery.
Range Biotechnologies
This company develops a proteomics platform for high-throughput protein quantification to support pharmaceutical companies and clinical laboratories with drug discovery and diagnostics.
Protillion Biosciences
This company develops a high-throughput protein engineering platform for pharmaceutical partners to accelerate the discovery and optimisation of therapeutic antibodies and binder drugs.
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
